NCT00109070View on ClinicalTrials.gov

A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Study Completion Date

April 30, 2003

Conditions
Colorectal Cancer
Interventions
DRUG

Avastin (bevacizumab)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY